Axiora Medical Axiora Medical

China Top Revision Knee Prosthesis Factories & Suppliers

High-Demand Joint Reconstruction Solutions, Advanced OEM/ODM Manufacturing & Global Regulatory Compliance for Complex Orthopedic Arthroplasty.

Understanding Revision Knee Arthroplasty: Macro Clinical Challenges

Solving complex bone loss, mechanical instability, and joint line restoration.

Revision Total Knee Arthroplasty (RTKA) represents one of the most challenging segments in reconstructive orthopedics. Unlike primary Total Knee Arthroplasty (TKA), which utilizes standard implants to replace worn joint surfaces, revision surgeries are performed to replace failed primary knee implants due to aseptic loosening, periprosthetic infection, mechanical instability, osteolysis, or periprosthetic fracture. The complexity of these procedures requires implant systems designed with modularity, structural support, and customizable fixation options to address varying levels of bone loss and joint instability.

Key clinical factors driving the choice of a revision knee prosthesis system include:

  • Bone Defect Management: Clinicians classify bone loss using systems like the Anderson Orthopaedic Research Institute (AORI) classification. Class I defects have intact metaphyseal bone, Class II has damaged metaphysis requiring reconstruction with metal augments or cones, and Class III represents massive bone loss requiring structural stem bypass or customized mega-prostheses.
  • Constraint Levels: Depending on ligamentous integrity, surgeons select varying levels of implant constraint, including Condylar Constrained Knee (CCK) systems or fully constrained Rotating Hinge Knee (RHK) systems. Balancing stability with joint kinematics is vital to prevent early aseptic loosening from excessive load transfer.
  • Joint Line Restoration: Re-establishing the anatomic joint line is critical to maintaining appropriate patellofemoral tracking and soft tissue tension, preventing postoperative stiffness or instability.

Industrial Capabilities & Metallurgy Standards

Advanced engineering specifications for medical-grade materials and biocompatibility.

Cobalt-Chromium (CoCrMo)

Utilized for articulating surfaces (femoral components) per ASTM F75 standards. Offers superior hardness, wear resistance, and high-fatigue strength to minimize particulate debris generation.

Titanium Alloy (Ti6Al4V ELI)

Complies with ASTM F136 requirements. Optimized for intramedullary stems, metaphyseal sleeves, and tibial trays. Provides an elastic modulus closer to cortical bone to reduce stress shielding.

UHMWPE & Highly Cross-Linked PE

Highly Cross-Linked Polyethylene (HXLPE) infused with Vitamin E options to mitigate oxidation, reducing long-term bearing wear and bone resorption risks.

Axiora Medical Technology (China) Co., Ltd.

Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.

Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.

With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery. Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.

2017
Year Established
18.6K m²
Factory Footprint
$26M
Annual Export Revenue
86
R&D Engineers
Item Details
Company Name Axiora Medical Technology (China) Co., Ltd.
Brand Axiora
Website www.axioraortho.com
Established 2017
Factory Area 18,600 m²
Annual Export Revenue USD 26 Million
Export Experience 8 Years
Industry Experience 15 Years
Quality Inspection 100% Finished Product Inspection & Incoming Material Inspection
Product Inspection Methods Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing
Quality Control Staff 48
Business Type Manufacturer & Exporter (OEM/ODM)
Main Markets Europe, North America, Middle East, Southeast Asia, South America
Supply Chain Partners 1,120
Main Customer Types Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects
R&D Capability Independent Product Development, Reverse Engineering, OEM & ODM Solutions
Customization Options Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing
New Products Released Last Year 126
R&D Engineers 86

Advanced Manufacturing & Quality Inspection Showcase

Strict clinical manufacturing process from high-grade raw materials to sterile packaging.

Raw Material
Raw Material
Longitudinal Cutting
Longitudinal Cutting
CNC Machining
CNC
Polishing
Polishing
Ultrasonic Washing 1
Ultrasonic Washing 1
Grinding
Grinding
Sand-Blasting
Sand-Blasting
Penetrant Testing
Penetrant Testing
Anodizing
Anodizing
Ultrasonic Washing 2
Ultrasonic Washing 2
OQC
OQC
Aseptic Packing Room
Aseptic Packing Room
Packing Line
Packing Line
Storage
Storage
Longitudinal Cutting Lathe
Longitudinal Cutting Lathe
CNC Machinery
CNC
Polishing Machine
Polishing Machine
Ultrasonic Washing Unit
Ultrasonic Washing Unit
Grinding Machine
Grinding Machine
Sand-Blasting Machine
Sand-Blasting Machine
Anodizing Machine
Anodizing Machine
Penetrant Testing Room
Penetrant Testing Room
Endurance Tester
Endurance Tester
Aging Tester
Aging Tester

Global Commercial & Local Support Compliance

Ensuring regulatory conformity, secure supply chains, and localized hospital support.

Global Regulatory Requirements

Medical implant devices belong to the highest regulatory risk class globally (Class III for US FDA and EU MDR 2017/745). To export joint prostheses globally, Chinese factories must maintain certified quality management systems operating under ISO 13485:2016. All raw medical-grade metals must provide full trace certificates, ensuring that every batch of titanium, cobalt-chromium, and ultra-high molecular weight polyethylene can be tracked from production to the final surgery.

Local Application Scenarios & Fitment

Modern revision knee prostheses utilize modular components to accommodate the anatomy of diverse global populations. Asian populations typically require smaller components with narrower dimensions compared to Western demographics. Top-tier manufacturers like Axiora offer extended size ranges for femoral condyles and tibial trays to ensure safe fitment across world markets without causing soft tissue impingement.

Hospital-Level Supply Integration

Revision surgeries are high-risk, unplanned, or semi-elective procedures that require rapid response. Axiora supports global distributors through reliable logistics partners and high-volume component availability, ensuring that hospitals have immediate access to complete surgical instrument systems and trials during challenging reconstructions.

Technical Roadmap & Future Outlook

The evolutionary trajectory of joint reconstruction systems and technology integrations.

The joint reconstruction industry is moving away from generic off-the-shelf components toward high-modularity and personalized solutions. The technological roadmap for joint prostheses includes three major developments:

  • 3D-Printed Trabecular Structures: Integrating additive manufacturing (selective laser melting/electron beam melting) to produce highly porous titanium structures that mimic human bone. This enhances secondary biological fixation and osseointegration, reducing reliance on bone cement.
  • Bioactive Coatings: Utilizing advanced plasma spraying technologies to apply Hydroxyapatite (HA) or diamond-like carbon (DLC) coatings, increasing scratch resistance and improving bone-to-implant interfaces.
  • Smart Implants & Digital Surgery: Combining computerized surgical navigation with patient-specific cutting guides (PSI) and robotic surgery interfaces to optimize component alignment, mitigating wear rates.

Clinical & Commercial Q&A

Answers to common procurement and technical implementation inquiries.

1. What are the key indications for selecting a Revision Knee Prosthesis?

Indications include aseptic loosening, mechanical failure, periprosthetic infection, joint instability, persistent pain, and bone loss from a prior primary total knee replacement.

2. How does Axiora assist with OEM/ODM customization for orthopedic implants?

We support drawing-based custom designs, reverse engineering, private label packaging, and material selection (CoCrMo, Titanium, UHMWPE) utilizing our internal R&D engineering team and CNC processing machinery.

3. What quality control procedures are implemented?

We perform 100% finished product inspections using CMM (Coordinate Measuring Machines), surface roughness tests, hardness verification, tensile strength evaluations, and endurance fatigue tests.

4. How do you handle AORI Class II and Class III bone defects?

Our system provides modular femoral and tibial augments, metal cones, and intramedullary stems to bypass defect zones, allowing stable distal/proximal mechanical load transfer.

5. What is the typical lead time for custom production runs?

Standard custom runs require 4 to 8 weeks depending on the configuration, drawing complexity, surface coating requirements, and sterilization/packaging needs.